Safety and Efficacy of Vilazodone in Pediatric Patients With Major Depressive Disorder (VLZ-MD-22)

NCT02372799 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

473

Enrollment

INDUSTRY

Sponsor class

Conditions

Major Depressive Disorder

Interventions

DRUG: Vilazodone
DRUG: Placebo
DRUG: Fluoxetine

Sponsor

Forest Laboratories